|
Chromavision(R) ACIS(TM) Selected by ImClone Systems For Use in Research and Development of New Cancer Therapies.
Publication: PR Newswire Publication Date: 31-MAY-01 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2001 PR Newswire Association LLC
SAN JUAN CAPISTRANO, Calif., May 31 /PRNewswire/ --
ChromaVision Medical Systems, Inc. (Nasdaq: CVSN), the leading provider of automated cell-imaging systems and manufacturer of the ACIS(TM) system, announced today that New York-based ImClone Systems Incorporated (Nasdaq: IMCL), will begin use of the ACIS system in research and development of new and existing therapeutics focused on oncology. ImClone Systems has built a large pipeline of drug candidates designed to target specific genetic mechanisms involved in cancer growth and development. ChromaVision and ImClone Systems share a common goal to provide fully-integrated testing...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from PR Newswire |
Chinese Sales Channels for Technology Products.
May 31, 2001
|
VIP Tone Redefines Portal Computing for Education With Acquisition of ...
May 31, 2001
|
Goodrich Receives Surveillance Equipment Contract from Japanese Defens...
May 31, 2001
|
WorldWater Corp. Chairman Quentin T. Kelly to Present at New York Soci...
May 31, 2001
|
Cingular Scores, Selecting Velocity Sports & Entertainment as Agency o...
May 31, 2001
|
|
| Find companies classified under Diagnostic substances |
| Find companies classified under Analytical instruments |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
